Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

‘Tremendous Hope’ Surrounds Emerging Therapies for Cancer That has Spread to the Brain

March 1st 2022

Better therapies are on the horizon for cancer that has spread to the brain, including a clinical trial that matches patients with treatments based on unique genetic changes in brain metastases.

Photoimmunotherapy Trial Begins in Certain Patients With Head and Neck, and Skin Cancer

February 22nd 2022

The goal of the phase 2 trial is to study the safety and efficacy of ASP-1929, a photoimmunotherapy with fluorescence imaging, in patients with head and neck or skin cancer.

What I Learned About Diversity, Equity and Inclusion in the Skin Cancer Space

February 11th 2022

I learned that a more prominent obstacle that we need to navigate is getting past the assumption that having a darker skin tone protects people from skin cancer.

Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival

January 28th 2022

Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.

FDA Approves Kimmtrak for Unresectable or Metastatic Uveal Melanoma

January 26th 2022

Kimmtrak is the first-ever drug to be granted FDA approval for this patient population of HLA-A*02:01-positive metastatic or unresectable uveal melanoma.

Cosibelimab Elicits Positive Tumor Response in Patients With Metastatic Skin Cancer Subtype

January 25th 2022

Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

Ronnie Spector Dies After Brief Spell With Cancer, Man Continues His Personal Health Advocacy After a Stranger Helped Discover His Cancer and More

January 14th 2022

From the deaths of singer Ronnie Spector and famed cancer researcher Beatrice Mintz to a patient who became his own biggest advocate after a stranger noticed a suspicious spot on his back, here’s what’s happening in the cancer landscape this week.

Increased Fiber Intake May Improve Immunotherapy Responses in Patients With Skin Cancer Subtype

January 10th 2022

Patients with melanoma who consumed a high-fiber diet may have a better response to immunotherapy, although the benefit was not as great if the fiber was obtained via probiotic supplements.

FDA Target Dates for Potential Cancer Drug Approvals in Early 2022

January 10th 2022

The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

New Drug Combo Boasts Improved Outcomes, Fewer Side Effects in Melanoma

January 7th 2022

Relatlimab plus Opdivo improved progression-free survival in patients with untreated, advanced melanoma, and tended to have fewer side effects than other regimens used in this patient population.

Some Allergy Medications May Positively Influence Immunotherapy Responses in Cancer, But Is Only ‘A Tip of the Iceberg’

January 6th 2022

Certain allergy medications like Zyrtec and Claritin may be the key for more patients to tolerate immunotherapy for several cancer types.

Families and Caregivers Must 'Juggle' Between Risks and Benefits of Treating Children with Skin Cancer

January 5th 2022

The recent FDA approval of Keytruda, an immunotherapy monoclonal antibody drug, for children with melanoma is an exciting development, according to an expert. But there is potential for certain side effects that children and their family should consider before undergoing treatment.

Genomic Features in Young Adults With Cancer May Differ Than in Older Patients, Which May Help Steer Treatment Decisions

December 27th 2021

As cancer incidence increases in young adults, understanding the genomic profiles of tumors in young adults may guide treatment options such as immunotherapy.

FDA’s Approval of New Keytruda Indication Yields Fresh Treatment Option for ‘Gigantic Group of Patients’ With Melanoma

December 22nd 2021

The FDA’s recent greenlight of a new Keytruda indication gives a large group of patients with melanoma access to a treatment option that they didn’t previously have, says an expert from the UPMC Hillman Cancer Center.

Winter Sun Protection: What You Need To Know

December 20th 2021

While it may be tempting to slack off on sun protection when the rays aren’t beating down, it’s imperative to stay vigilant through the darker winter months.

Top 5 Skin Cancer-Related Articles of 2021

December 15th 2021

Here’s a look back at CURE®’s top-performing melanoma content from the year 2021.

FDA Approves Adjuvant Keytruda for Pediatric and Adult Melanoma

December 4th 2021

The FDA approved adjuvant Keytruda for patients ages 12 and older with stage 2b, 2c or 3 melanoma that has been completely resected.

Melanoma Treatment Results Were So Good, Researchers Ended the Trial

November 29th 2021

Upfront immunotherapy was far superior to upfront BRAF/MEK inhibition in patients with metastatic BRAFV600-mutant melanoma, causing the phase 3 DREAMseq early to stop early.

Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma

November 26th 2021

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

Immunotherapy Combo May ‘Potentially Cure’ Melanoma With Brain Metastases

November 18th 2021

The combination of Opdivo and Yervoy may provide a survival benefit for asymptomatic patients with melanoma who have brain metastases, although more efforts are needed to include this patient population in trials.

Side Effects From Immune Checkpoint Inhibitors May Increase Hospitalizations, Cost for Patients With Bladder, Liver, Lung or Skin Cancer

November 4th 2021

Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.

First Patient With Squamous Cell Carcinoma Dosed in Phase 2 Trial for Vilobelimab

October 17th 2021

The first patient was enrolled and dosed in InflaRx’s phase 2 trial of vilobelimab for the treatment of cutaneous squamous cell carcinoma.

Certain Blood Pressure Drugs May Increase Skin Cancer Risk

September 20th 2021

Exposure to certain high blood pressure drugs, specifically thiazide diuretics, may increase a person’s risk of developing skin cancer.

Gut Microbiome Can Affect Radiation Cancer Treatment

September 14th 2021

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Climate Change May Increase Skin Cancer Risk

September 1st 2021

Skin cancer rates have been increasing worldwide, and climate change factors – like depleting ozone layers – may be a factor.

Legendary ESPN Broadcaster Dick Vitale Reveals Skin Cancer Diagnosis, Patient With Cancer Receives COVID-19 Booster Shot and More

August 20th 2021

From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.

Gut Health May Impact Side Effects Risk From Certain Melanoma Treatment

August 17th 2021

The bacteria in a patient’s gut could be linked to side effects from combined checkpoint inhibitors in patients with melanoma.

5 Ways to Support Your Mental Wellness During Radiation Therapy

August 15th 2021

Here are five options for overcoming stress and anxiety to promote your mental wellness and emotional resilience during your radiation therapy.

Obtain Vitamin D Safely Through Diet and Vitamin Supplements, Not with Unprotected Sun Exposure

August 2nd 2021

Vitamin D is essential for strong bones and a healthy immune system. While a limited amount of the vitamin can be obtained from exposure to the sun’s ultraviolet (UV) radiation, the suggestion that the best way to obtain vitamin D is through sun exposure is both misleading and dangerous.

Could Your UV Manicure Increase Your Risk for Skin Cancer?

August 1st 2021

What you should know about UV manicures and cancer risk.

NEXT PAGE
PREVIOUS PAGE